Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes

Y-T Tang; D Wang; H Luo; M Xiao; H-S Zhou; D Liu; S-P Ling; N Wang; X-L Hu; Y Luo; X Mao; Q-L Ao; J Huang; W Zhang; L-S Sheng; L-J Zhu; Z Shang; L-L Gao; P-L Zhang; M Zhou; K-G Zhou; L-G Qiu; Q-F Liu; H-Y Zhang; J-Y Li; J Jin; L Fu; W-L Zhao; J-P Chen; X Du; G Huang; Q-F Wang; J-F Zhou; L Huang

doi:10.1038/s41408-017-0021-z

Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes

Blood Cancer J. 2017 Dec 21;7(12):660. doi: 10.1038/s41408-017-0021-z.

Authors

Y-T Tang¹, D Wang¹, H Luo¹, M Xiao¹, H-S Zhou², D Liu³, S-P Ling³, N Wang¹, X-L Hu¹, Y Luo¹, X Mao¹, Q-L Ao⁴, J Huang¹, W Zhang¹, L-S Sheng¹, L-J Zhu¹, Z Shang¹, L-L Gao¹, P-L Zhang¹, M Zhou¹, K-G Zhou¹, L-G Qiu⁵, Q-F Liu², H-Y Zhang⁶, J-Y Li⁷, J Jin⁸, L Fu⁹, W-L Zhao¹⁰, J-P Chen¹¹, X Du¹², G Huang^{13

14}, Q-F Wang^{3

5

15}, J-F Zhou^{1

5

16}, L Huang^{17

18}

Affiliations

¹ Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
² Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
³ Key Laboratory of Genomic and Precision Medicine, Collaborative Innovation Center of Genetics and Development, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.
⁴ Department of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
⁵ Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjing, China.
⁶ Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China.
⁷ Department of Hematology, the First Affiliated Hospital of Nanjing Medical University and Jiangsu Province Hospital, Nanjing, China.
⁸ Department of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, China.
⁹ Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
¹⁰ Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Shanghai Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
¹¹ Department of Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China.
¹² Department of Hematology, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.
¹³ Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
¹⁴ Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
¹⁵ University of Chinese Academy of Sciences, Beijing, China.
¹⁶ Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
¹⁷ Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. lhuang@tjh.tjmu.edu.cn.
¹⁸ Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. lhuang@tjh.tjmu.edu.cn.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
China
Female
Humans
Leukemia, Large Granular Lymphocytic / epidemiology*
Leukemia, Large Granular Lymphocytic / pathology*
Leukemia, Large Granular Lymphocytic / therapy*
Male
Retrospective Studies
Treatment Outcome
Young Adult